Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

17.21

-0.76 (-4.23%)

At close: Mar 20, 2026, 4:00 PM EDT

17.52

+0.31 (1.78%)

After-hours: Mar 20, 2026, 7:54 PM EDT

Apellis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	466.23	411.29	351.19	551.8	640.19
Short-Term Investments	-	-	-	-	60.36
Cash & Short-Term Investments	466.23	411.29	351.19	551.8	700.55
Cash Growth	13.36%	17.11%	-36.36%	-21.23%	-20.18%
Accounts Receivable	366.22	264.93	206.44	7.73	10.1
Inventory	142.56	81.4	146.36	85.71	16.29
Other Current Assets	39.83	31.33	62.34	74.28	97.11
Total Current Assets	1,015	788.95	766.33	719.52	824.05
Net Property, Plant & Equipment	19.9	19.04	21.09	24.9	26.08
Other Long-Term Assets	40.51	77.06	1.31	15.8	31.64
Total Assets	1,075	885.05	788.73	760.22	881.77
Accounts Payable	56.8	38.57	37.52	37.34	16.91
Accrued Expenses	166.05	140.18	127.81	95.14	103.24
Current Portion of Leases	7.09	6.75	6.44	5.63	4.12
Other Current Liabilities	93.66	-	75.83	29.5	7.58
Total Current Liabilities	323.6	185.51	247.59	167.61	131.85
Long-Term Debt	-	93.34	93.03	92.74	189.02
Long-Term Leases	11.95	10.2	11.45	14.35	17.08
Other Long-Term Liabilities	369.57	367.46	242.13	315.65	345.15
Total Long-Term Liabilities	381.51	471	346.62	422.74	551.26
Total Liabilities	705.11	656.51	594.21	590.35	683.1
Common Stock	0.01	0.01	0	0.01	0.01
Additional Paid-in Capital	3,385	3,267	3,036	2,480	1,857
Accumulated Other Comprehensive Income	-2.1	-3.31	-3.54	-0.88	-2.09
Retained Earnings	-3,013	-3,035	-2,837	-2,309	-1,657
Shareholders' Equity	370.15	228.54	194.52	169.87	198.66
Total Liabilities & Equity	1,075	885.05	788.73	760.22	881.77
Total Debt	19.03	110.3	110.93	112.71	210.22
Net Cash (Debt)	447.2	301	240.26	439.09	490.33
Net Cash Growth	48.57%	25.28%	-45.28%	-10.45%	-1.92%
Net Cash Per Share	3.44	2.43	2.02	4.14	5.81
Book Value	370.15	228.54	194.52	169.87	198.66
Book Value Per Share	2.85	1.84	1.64	1.60	2.35
Tangible Book Value	370.15	228.54	194.52	169.87	198.66
Tangible Book Value Per Share	2.85	1.84	1.64	1.60	2.35

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q